Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vericiguat QT/QTc evaluation in patients with stable coronary artery disease
NL-OMON46553Completed
- Sponsor
- Bayer
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in heart failure (HF) comparing Vericiguat up-titration arm with Placebo arm with nested moxifloxacin positive control (2 arms). Primary endpoint: Primary QTcF endpoint. Started Jul 2018; status: completed.
02
Drugs
vericiguat
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NL-OMON46553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46553.